Boston Scientific Tweaks Full-Year Guidance to Narrow Range

By Matt Grossman

Boston Scientific Corp. on Wednesday adjusted its full-year earnings guidance by narrowing the forecast range compared with previous guidance.

For the full year, the medical-devices company said it now expects sales growth of 19% to 20% compared with last year, and adjusted earnings of $1.60 a share to $1.62 a share. In July, Boston Scientific had forecast adjusted earnings of $1.58 a share to $1.62 a share for the full year.

In the fourth quarter, Boston Scientific anticipates year-over year sales growth of 13% to 17% and adjusted earnings of 43 cents to 45 cents a share.

Write to Matt Grossman at [e-mail]

(END) Dow Jones Newswires

10-27-21 0659ET